Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000

Stock Information for Pulse Biosciences Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pulse Biosciences Inc

Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA(TM)) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
Pulse Biosciences Enhances Executive Leadership Team
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
Pulse Biosciences Announces Plans to Initiate a Rights Offering
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.